LLYX
Leveraged Long
Defiance Daily Target 2X Long LLY ETF
Distribution Rate *
-%
Payable As of
Distribution Frequency
Monthly
30-Day SEC Yield **
As of —
-%
Defiance Daily Target 2X Long LLY ETF
The Defiance Daily Target 2X Long LLY ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Eli Lilly and Company (NYSE: LLY”) (the “Underlying Security” or “LLY”). LLYX does not invest directly in LLY. Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds. It is also riskier than alternatives that do not use leverage. There is no guarantee that the Fund will meet its stated objective. The fund should not be expected to provide 2 times the cumulative return of LLY for periods greater than a day.
Underlying Stock: Eli Lilly and Company (“LLY”)
LLY is a global pharmaceutical company, which is dedicated to discovering, developing, manufacturing, and marketing innovative medicines in various therapeutic areas, including neuroscience, endocrinology, oncology, cardiovascular diseases, and immunology. LLY’s portfolio encompasses a wide range of prescription drugs, biologics, and animal health products. LLY is listed on the New York Stock Exchange (“NYSE”).
LLYXMarket Price
Performance
| YTD | 1 Month | 3 Months | 6 Months | Since Inception | |
|---|---|---|---|---|---|
| Total Return NAV (%) | -5.81% | 37.63% | 3.35% | -7.31% | 23.24% |
| Market Price (%) | -5.77% | 39.98% | 3.67% | -6.95% | 23.38% |
| 1 Year | 3 Years | 5 Years | Since Inception | |
|---|---|---|---|---|
| Total Return (%) | 71.24% | xx.xx% | xx.xx% | 12.21% |
| Market Price (%) | 71.60% | xx.xx% | xx.xx% | 12.28% |
| YTD | 1 Month | 3 Months | 6 Months | Since Inception | |
|---|---|---|---|---|---|
| Total Return NAV (%) | -31.95% | -25.33% | -31.95% | 27.92% | -10.95% |
| Market Price (%) | -32.05% | -25.25% | -32.05% | 28.14% | -11.01% |
| 1 Year | 3 Years | 5 Years | Since Inception | |
|---|---|---|---|---|
| Total Return (%) | -9.16% | xx.xx% | xx.xx% | -6.80% |
| Market Price (%) | -9.40% | xx.xx% | xx.xx% | -6.84% |
| YTD | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| Total Return (NAV) (%) | — | — | — | — | — | — | — |
| Market Price (%) | — | — | — | — | — | — | — |
| 1 Year | Since Inception | |
|---|---|---|
| Total Return (NAV) (%) | — | — |
| Market Price (%) | — | — |
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. Performance current to the most recent month-end can be obtained by calling 833.333.9383.
Short term performance, in particular, is not a good indication of the fund’s future performance, and an investment should not be made based solely on returns.
Market price is the price at which shares in the ETF can be bought or sold on the exchanges during trading hours, while the net asset value (NAV) represents the value of each share’s portion of the fund’s underlying assets and cash at the end of the trading day.
Fund Details
Data as of 06/12/2026
Net Assets
$70.62M
Premium/Discount
-0.04%
NAV
$25.00
Closing Price
$24.99
Shares Outstanding
2,825,000
Median 30 Day Spread
0.25%
Fund Inception
08/07/2024
Ticker
LLYX
Primary Exchange
NYSE
CUSIP
88636J261
Fund Holdings
10
NAV Symbol
LLYX.NV
Expense Ratio
1.29%
30 Day SEC Yield*
0.11%
* Yield as of 05-31-2026
Top Holdings
| Name | Symbol | Stock Price | % Net Assets | Shares Held | Market Value |
|---|---|---|---|---|---|
| Eli Lilly & Co Swap Ms | 532457108-TRS-10/16/28-L-LLYX | $1.00 | 35.94% | 22,400 | $25,379,200 |
| Eli Lilly & Co Swap Marex | 532457108-TRS-10/02/26-L-LLYX | $1.00 | 30.31% | 18,892 | $21,404,636 |
| Eli Lilly & Co Swap Cs | 532457108-TRS-10/13/26-L-LLYX | $1.00 | 29.18% | 18,186 | $20,604,738 |
| Eli Lilly & Co Swap Cantor – L | 532457108-TRS-09/08/28-L-LLYX | $1.00 | 28.34% | 17,667 | $20,016,711 |
| Lly Swap Nomura | 532457108-TRS-03/31/33-L-LLYX | $1.00 | 28.17% | 17,558 | $19,893,214 |
| Eli Lilly And Company-swap-nbcb-l | 532457108-TRS-01/31/33-L-LLYX | $1.00 | 27.78% | 17,315 | $19,617,895 |
| Eli Lilly & Co Swap Bmo | 532457108-TRS-103026-L-LLYX | $1.00 | 20.20% | 12,594 | $14,269,002 |
| First American Government Obligations Fund 12/01/2031 | FGXXX | $100.00 | 15.84% | 11,185,888 | $11,185,888 |
| United States Treasury Bill 06/25/2026 | 912797TE7 | $99.90 | 10.88% | 7,690,000 | $7,682,310 |
| Cash & Other | Cash&Other | $1.00 | -126.66% | -89,453,992 | $-89,453,992 |
Data as of 06/15/2026. Fund holdings are subject to change at any time and should not be considered recommendations to buy or sell any security.
Fund Documents
Prospectus
Summary Prospectus
SAI
Semi-Annual Report
Core Financial Statements
10-31-25 Semi-Annual TSR
Semi-Annual 10-31-25 Financial Statements
Q1 Holdings 07-31-2025
Annual 4-30-25 TSR
Annual 4-30-25 Financial Statement
2025 ICI Primary
Q3 Holdings
2025 Tax Insert
Premium Discount Graph (03/31/2026)
Distributions
Declaration Date |
Ex-Div Date |
Record Date |
Payable Date |
Amount ($) |
|---|---|---|---|---|
12/29/2026 |
12/30/2026 |
12/30/2026 |
12/31/2026 |
$– |
12/29/2025 |
12/30/2025 |
12/30/2025 |
12/31/2025 |
$0.70416914 |
| Declaration Date | Ex-Div Date | Record Date | Payable Date | Amount ($) | |
|---|---|---|---|---|---|
| 12/29/2025 | 12/30/2025 | 12/30/2025 | 12/31/2025 | $0.70416914 |